Tag Archives: KEYNOTE-006

New Link’s Indoximod + Keytruda looks promising in Phase 2 advanced melanoma

Indoximod + Keytruda looks promising in Phase 2 advanced melanoma

IDO (indoleamine-2,3-dioxygenase) is an intracellular enzyme found in antigen presenting cells that mediates immune suppression in the tumor microenvironment. Continue reading